High-risk screening for Fabry disease in hemodialysis patients in Chiba Prefecture, Japan.

Toshiyuki ImasawaKei MurayamaTakaaki SawadaMasanori HiroseMasaki TakayanagiKimitoshi Nakamura

Published in: Clinical and experimental nephrology (2022)

The prevalence of Fabry disease among patients undergoing hemodialysis in Chiba Prefecture was estimated as 0.03%. This is the first time that dialysis has been shown to affect the αGal A activity.

Keyphrases

patients undergoing
chronic kidney disease
replacement therapy
end stage renal disease
risk factors
hypertrophic cardiomyopathy
heart failure